000274077 001__ 274077
000274077 005__ 20240229154925.0
000274077 0247_ $$2doi$$a10.1038/s41375-023-01852-w
000274077 0247_ $$2ISSN$$a0887-6924
000274077 0247_ $$2ISSN$$a1476-5551
000274077 0247_ $$2altmetric$$aaltmetric:142918984
000274077 037__ $$aDKFZ-2023-00423
000274077 082__ $$a610
000274077 1001_ $$0P:(DE-He78)19b0ec1cea271419d9fa8680e6ed6865$$aHemminki, Kari$$b0$$eFirst author$$udkfz
000274077 245__ $$aSurvival in hematological malignancies in the Nordic countries through a half century with correlation to treatment
000274077 260__ $$aLondon$$bSpringer Nature$$c2023
000274077 3367_ $$2DRIVER$$aarticle
000274077 3367_ $$2DataCite$$aOutput Types/Journal article
000274077 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1681213203_5541
000274077 3367_ $$2BibTeX$$aARTICLE
000274077 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000274077 3367_ $$00$$2EndNote$$aJournal Article
000274077 500__ $$a#EA:C020# / 2023 Apr;37(4):854-863
000274077 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000274077 588__ $$aDataset connected to CrossRef, Journals: inrepo02.dkfz.de
000274077 7001_ $$aHemminki, Janne$$b1
000274077 7001_ $$0P:(DE-He78)f26164c08f2f14abcf31e52e13ee3696$$aFörsti, Asta$$b2$$udkfz
000274077 7001_ $$00000-0002-6133-0164$$aSud, Amit$$b3
000274077 773__ $$0PERI:(DE-600)2008023-2$$a10.1038/s41375-023-01852-w$$n4$$p854-863$$tLeukemia$$v37$$x0887-6924$$y2023
000274077 909CO $$ooai:inrepo02.dkfz.de:274077$$pVDB
000274077 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)19b0ec1cea271419d9fa8680e6ed6865$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000274077 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)f26164c08f2f14abcf31e52e13ee3696$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000274077 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000274077 9141_ $$y2023
000274077 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2022-11-18$$wger
000274077 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2022-11-18
000274077 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2022-11-18
000274077 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2022-11-18
000274077 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-08-23
000274077 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-08-23
000274077 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2023-08-23
000274077 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-08-23
000274077 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2023-08-23
000274077 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bLEUKEMIA : 2022$$d2023-08-23
000274077 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-08-23
000274077 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2023-08-23
000274077 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2023-08-23
000274077 915__ $$0StatID:(DE-HGF)9910$$2StatID$$aIF >= 10$$bLEUKEMIA : 2022$$d2023-08-23
000274077 9201_ $$0I:(DE-He78)C020-20160331$$kC020$$lC020 Epidemiologie von Krebs$$x0
000274077 9201_ $$0I:(DE-He78)B062-20160331$$kB062$$lB062 Pädiatrische Neuroonkologie$$x1
000274077 9201_ $$0I:(DE-He78)HD01-20160331$$kHD01$$lDKTK HD zentral$$x2
000274077 9200_ $$0I:(DE-He78)C020-20160331$$kC020$$lC020 Epidemiologie von Krebs$$x0
000274077 980__ $$ajournal
000274077 980__ $$aVDB
000274077 980__ $$aI:(DE-He78)C020-20160331
000274077 980__ $$aI:(DE-He78)B062-20160331
000274077 980__ $$aI:(DE-He78)HD01-20160331
000274077 980__ $$aUNRESTRICTED